{"disease":{"id":"influenza-pandemic","name":"influenza pandemic"},"drugs":{"marketed":[{"drug_id":"favipiravir","indication_name":"Influenza caused by pandemic influenza virus","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Avigan","generic_name":"FAVIPIRAVIR","company_name":"Toyama Chemical Co., Ltd.","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":16,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07240558","title":"Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT07111078","title":"Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":56,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT05397119","title":"A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"BlueWillow Biologics","has_results":false},{"nct_id":"NCT06046092","title":"H7HLAII DNA Influenza Vaccine","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":27,"lead_sponsor_name":"Oslo University Hospital","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}